GETINGE Gross Profit 2016-2026 | GNGBY
GETINGE annual/quarterly gross profit history and growth rate from 2016 to 2026. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
- GETINGE gross profit for the quarter ending June 30, 2026 was $0.472B, a 15.6% increase year-over-year.
- GETINGE gross profit for the twelve months ending June 30, 2026 was $1.776B, a 11.31% increase year-over-year.
- GETINGE annual gross profit for 2025 was $1.702B, a 11.38% increase from 2024.
- GETINGE annual gross profit for 2024 was $1.528B, a 11.79% increase from 2023.
- GETINGE annual gross profit for 2023 was $1.367B, a 2.86% increase from 2022.
|
GETINGE Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2025 | $1,702 |
| 2024 | $1,528 |
| 2023 | $1,367 |
| 2022 | $1,329 |
| 2021 | $1,583 |
| 2020 | $1,605 |
| 2019 | $1,318 |
| 2018 | $1,272 |
| 2017 | $1,244 |
| 2016 | $1,618 |
| 2015 | $1,680 |
|
GETINGE Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2026-06-30 | $472 |
| 2026-03-31 | $394 |
| 2025-12-31 | $509 |
| 2025-09-30 | $401 |
| 2025-06-30 | $408 |
| 2025-03-31 | $384 |
| 2024-12-31 | $462 |
| 2024-09-30 | $341 |
| 2024-06-30 | $375 |
| 2024-03-31 | $349 |
| 2023-12-31 | $404 |
| 2023-09-30 | $332 |
| 2023-06-30 | $294 |
| 2023-03-31 | $336 |
| 2022-12-31 | $361 |
| 2022-09-30 | $321 |
| 2022-06-30 | $320 |
| 2022-03-31 | $327 |
| 2021-12-31 | $446 |
| 2021-09-30 | $362 |
| 2021-06-30 | $407 |
| 2021-03-31 | $367 |
| 2020-12-31 | $473 |
| 2020-09-30 | $466 |
| 2020-06-30 | $358 |
| 2020-03-31 | $308 |
| 2019-12-31 | $424 |
| 2019-09-30 | $306 |
| 2019-06-30 | $304 |
| 2019-03-31 | $283 |
| 2018-12-31 | $398 |
| 2018-09-30 | $271 |
| 2018-06-30 | $307 |
| 2018-03-31 | $297 |
| 2017-12-31 | $90 |
| 2017-09-30 | $393 |
| 2017-06-30 | $392 |
| 2017-03-31 | $369 |
| 2016-12-31 | $491 |
| 2016-09-30 | $384 |
| 2016-06-30 | $386 |
| 2016-03-31 | $357 |
| 2015-12-31 | $1,107 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $6.654B | $3.574B |
| Getinge AB develops, manufactures and sells products and services for operating rooms, intensive-care units, hospital wards, sterilization departments, elderly care for life science companies and institutions. The company's operating segments consists of Medical Systems, Extended Care and Infection Control. It operates primarily in the United Kingdom, France, the United States and Australia. Getinge AB is headquartered in Gothenburg, Sweden. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $142.882B | 25.03 |
| CVS Health (CVS) | United States | $122.206B | 12.19 |
| HCA Healthcare (HCA) | United States | $92.119B | 14.32 |
| Elevance Health (ELV) | United States | $92.005B | 14.44 |
| Cencora (COR) | United States | $62.254B | 19.02 |
| Natera (NTRA) | United States | $49.267B | 0.00 |
| Labcorp Holdings (LH) | United States | $25.572B | 18.03 |
| Viatris (VTRS) | United States | $19.136B | 6.61 |
| Medpace Holdings (MEDP) | United States | $16.619B | 34.90 |
| DiDi Global (DIDIY) | China | $16.275B | 178.51 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $16.114B | 0.00 |
| Solventum (SOLV) | United States | $15.290B | 12.65 |
| Revvity (RVTY) | United States | $14.338B | 24.02 |
| Charles River Laboratories (CRL) | United States | $13.038B | 27.59 |
| ICON (ICLR) | Ireland | $12.935B | 17.58 |
| BrightSpring Health Services (BTSG) | United States | $11.931B | 41.02 |
| Avantor (AVTR) | United States | $10.254B | 18.49 |
| BioMerieux (BMXMF) | France | $10.192B | 0.00 |
| HealthEquity (HQY) | United States | $7.944B | 25.89 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.362B | 72.36 |
| PACS (PACS) | United States | $7.051B | 23.70 |
| Sonic Healthcare (SKHHY) | Australia | $6.687B | 0.00 |
| CochLear (CHEOY) | Australia | $6.355B | 0.00 |
| Bausch + Lomb (BLCO) | Canada | $6.282B | 23.76 |
| MiniMed (MMED) | United States | $6.181B | 0.00 |
| Sotera Health (SHC) | United States | $5.285B | 21.79 |
| Concentras Parent (CON) | United States | $4.566B | 22.52 |
| Organon (OGN) | United States | $3.585B | 4.55 |
| CareDx (CDNA) | United States | $2.709B | 308.06 |
| Alignment Healthcare (ALHC) | United States | $2.684B | 68.11 |
| GeneDx Holdings (WGS) | United States | $2.676B | 249.28 |
| Amplifon S.p.A (AMFPF) | Italy | $2.466B | 12.74 |
| Pediatrix Medical (MD) | United States | $2.187B | 12.81 |
| Establishment Labs Holdings (ESTA) | United States | $2.143B | 0.00 |
| Progyny (PGNY) | United States | $2.137B | 30.27 |
| COMPASS Pathways (CMPS) | United Kingdom | $2.013B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $1.914B | 0.00 |
| Surgery Partners (SGRY) | United States | $1.838B | 70.20 |
| Bora Pharmaceuticals, - (BORAY) | Taiwan | $1.695B | 10.18 |
| Freenome (FRNM) | United States | $1.607B | 0.00 |
| Ardent Health (ARDT) | United States | $1.552B | 8.87 |
| Agilon Health (AGL) | United States | $1.551B | 0.00 |
| Nutex Health (NUTX) | United States | $1.486B | 8.52 |
| InnovAge Holding (INNV) | United States | $1.470B | 0.00 |
| Omada Health (OMDA) | United States | $1.255B | 256.25 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.241B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.220B | 23.73 |
| Teladoc Health (TDOC) | United States | $1.181B | 0.00 |
| CryoPort (CYRX) | United States | $0.808B | 0.00 |
| GMR Solutions (GMRS) | United States | $0.716B | 0.00 |
| Enhabit (EHAB) | United States | $0.709B | 25.89 |
| Forward Industries (FWDI) | United States | $0.513B | 0.00 |
| Oncology Institute (TOI) | United States | $0.507B | 0.00 |
| Charming Medical (MCTA) | Hong Kong, SAR China | $0.504B | 0.00 |
| Strata Critical Medical (SRTA) | United States | $0.474B | 0.00 |
| SBC Medicals (SBC) | United States | $0.467B | 9.66 |
| Shoulder Innovations (SI) | United States | $0.382B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.377B | 5.47 |
| Embecta (EMBC) | United States | $0.297B | 2.57 |
| Biodesix (BDSX) | United States | $0.289B | 0.00 |
| So-Young (SY) | China | $0.266B | 0.00 |
| LifeMD (LFMD) | United States | $0.166B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.109B | 0.00 |
| Park Dental Partners (PARK) | United States | $0.101B | 0.00 |
| SkinHealth Systems (SKIN) | United States | $0.091B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.079B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.065B | 7.65 |
| Tevogen (TVGN) | United States | $0.049B | 0.00 |
| DocGo (DCGO) | United States | $0.037B | 0.00 |
| Lifeward (LFWD) | United States | $0.020B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.014B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.014B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.011B | 0.00 |
| Ainos (AIMD) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.008B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.007B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.007B | 0.00 |
| 20/20 Biolabs (AIDX) | United States | $0.007B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.006B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.006B | 0.00 |
| Pomdoctor - (POM) | China | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.004B | 0.00 | |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Synergy CHC (SNYR) | United States | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |